Le code de l'épissage et sa modulation thérapeutique par des molécules chimiques

No abstract is available for this paper.

• Publication year

  2005

• Venue

  M S-medecine Sciences

• Publication date

  2005-10-01

• Fields of study

  Not labeled

• Identifiers
  DOI 10.1051/MEDSCI/20052110793
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Selective Inhibition of Topoisomerase I and Various Steps of Spliceosome Assembly by Diospyrin Derivatives

  2005cited by this paper
• [Selective modification of alternative splicing by indole derivatives that target SR protein splicing factors].

  2005cited by this paper
• The SR Protein SC35 Is Responsible for Aberrant Splicing of the E1α Pyruvate Dehydrogenase mRNA in a Case of Mental Retardation with Lactic Acidosis

  2005cited by this paper
• The spliceosome: a novel multi-faceted target for therapy.

  2005cited by this paper
• Selective modification of alternative splicing by indole derivatives that target serine-arginine-rich protein splicing factors.

  2005cited by this paper
• Finishing the euchromatic sequence of the human genome

  2004cited by this paper
• Phosphorylation-dependent control of the pre-mRNA splicing machinery.

  2003cited by this paper
• Genome-Wide Survey of Human Alternative Pre-mRNA Splicing with Exon Junction Microarrays

  2003cited by this paper
• Specific phosphorylation of SR proteins by mammalian DNA topoisomerase I

  1996cited by this paper

• Substances that can change alternative splice-site selection.

  2008cites this paper
• SR proteins as potential targets for therapy.

  2006cites this paper
• Pre-mRNA missplicing as a cause of human disease.

  2006cites this paper
• The spliceosome: a novel multi-faceted target for therapy.

  2005cites this paper
• L’épissage alternatif : une nouvelle cible pharmacologique aux potentialités thérapeutiques très larges

  2005cites this paper